SALIVARY BIOMARKERS OF INFLAMMATION IN RESPONSE TO DENTAL MATERIALS IN ORAL PRECANCEROUS CONDITIONS IN AFGHAN POPULATION
Main Article Content
Keywords
Saliva, Biomarkers, Inflammation, Dental materials, Oral precancerous conditions, Cytokines.
Abstract
: Salivary biomarkers are non-invasive, cost-effective means to assess inflammatory responses and identify precancerous lesions in the oral cavity. The dental materials that are used may have an impact on local inflammation, altering the course of the disease and the state of the mucosa.
Objective: The primary purpose of the study was to measure the salivary biomarkers of inflammation (IL-1β, IL-6, and IL-8) generated in response to dental materials in patients with oral precancerous conditions in Afghan population.
Methods: A study was performed during the period September, 2024 to February, 2025 at National Stomatology Curative and Specialty Hospital, Kabul, Afghanistan. The study comprised 40 patients with oral precancerous lesions, who were randomly assigned to two groups: composite resin and amalgam.
Results: Significant increases in IL-1β, IL-6, and IL-8 were observed at 1-week post-treatment, especially in the composite resin group, followed by a gradual decline over two months.
Conclusion: Dental materials trigger transient inflammatory responses; salivary biomarkers can effectively monitor oral inflammation.
References
2. Dongiovanni P, Meroni M, Casati S, Goldoni R, Thomaz DV, Kehr NS, Galimberti D, Del Fabbro M, Tartaglia GM. Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. International journal of oral science. 2023 Jun 29;15(1):27.
3. Dongiovanni P, Meroni M, Casati S, Goldoni R, Thomaz DV, Kehr NS, Galimberti D, Del Fabbro M, Tartaglia GM. Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation. International journal of oral science. 2023 Jun 29;15(1):27.
4. Kiyomi A, Yoshida K, Arai C, Usuki R, Yamazaki K, Hoshino N, Kurokawa A, Imai S, Suzuki N, Toyama A, Sugiura M. Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: A pilot study. PLoS One. 2022 Apr 27;17(4):e0267092.
5. Shakeeb N, Varkey P, Ajit A. Human saliva as a diagnostic specimen for early detection of inflammatory biomarkers by real-time RT-PCR. Inflammation. 2021 Oct;44(5):1713-23.
6. Papale F, Santonocito S, Polizzi A, Giudice AL, Capodiferro S, Favia G, Isola G. The new era of salivaomics in dentistry: frontiers and facts in the early diagnosis and prevention of oral diseases and cancer. Metabolites. 2022 Jul 12;12(7):638.
7. Principe S, Zapater-Latorre E, Arribas L, Garcia-Miragall E, Bagan J. Salivary IL-8 as a putative predictive biomarker of radiotherapy response in head and neck cancer patients. Clinical Oral Investigations. 2022 Jan;26(1):437-48.
8. Vats R, Yadav P, Bano A, Wadhwa S, Bhardwaj R. Salivary biomarkers in non-invasive oral cancer diagnostics: a comprehensive review. Journal of Applied Oral Science. 2024 Sep 9;32:e20240151.
9. Arroyo E, Donís SP, Petronacci CM, Alves MG, Mendía XM, Fernandes D, Pouso AI, Bufalino A, Bravo Lopez S, Sayáns MP. Usefulness of protein-based salivary markers in the diagnosis of oral potentially malignant disorders: A systematic review and meta-analysis. Cancer Biomarkers. 2021 Nov;32(4):411-24.
10. Arbildo Vega HI, Panda S, Vásquez-Rodrigo H, Aguirre R, Meza J, Lujan Valencia SA, Lujan-Urviola E, Farje-Gallardo CA, Castillo-Cornock TB, Serquen-Olano K, Padilla-Cáceres T. Salivary biomarkers in the prognostic of oncological and infectious diseases. A systematic review. Frontiers in Dental Medicine. 2025 Sep 29;6:1662276.
11. Piyarathne NS, Rasnayake RM, Angammana R, Chandrasekera P, Ramachandra S, Weerasekera M, Yasawardene S, Abu-Eid R, Jayasinghe JP, Gupta E. Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors–A systematic review. Expert Review of Molecular Diagnostics. 2021 Aug 3;21(8):789-807.
12. Rodríguez-Molinero J, del Carmen Migueláñez-Medrán B, Delgado-Somolinos E, Carreras-Presas CM, López-Sánchez AF. Advances in the diagnosis, monitoring, and progression of oral cancer through saliva: an update. BioMed Research International. 2022;2022(1):2739869.
13. Benito-Ramal E, Egido-Moreno S, González-Navarro B, Jané-Salas E, Roselló-Llabrés X, López-López J. Role of selected salivary inflammatory cytokines in the diagnosis and prognosis of oral squamous cell carcinoma. A Systematic Review and Meta-analysis. Medicina Oral, Patologia Oral y Cirugia Bucal. 2023 Apr 26;28(5):e474.
14. López-Jornet P, Olmo-Monedero A, Peres-Rubio C, Pons-Fuster E, Tvarijonaviciute A. Preliminary Evaluation Salivary Biomarkers in Patients with Oral Potentially Malignant Disorders (OPMD): A Case–Control Study. Cancers. 2023 Nov 1;15(21):5256.
15. Adamov A, Bolyarova-Konova T, Stanimirov P, Aleksiev E, Kandilarova SM, Miteva M, Yankova P, Ishkitiev N, Mihaylova Z. Cytokines levels in saliva in periodontitis, oral potentially malignant disorders and squamous cell carcinoma. Biotechnology & Biotechnological Equipment. 2024 Dec 31;38(1):2423777.
16. Nosratzehi T, Nosratzehi S. Oral cancer and salivary biomarkers in its early diagnosis: A review of literature. Journal of Medical Society. 2024 Jan 1;38(1):8-15.
17. Matsuoka M, Soria SA, Pires JR, Sant’Ana AC, Freire M. Natural and induced immune responses in oral cavity and saliva. BMC immunology. 2025 Apr 18;26(1):34.
18. Senevirathna K, Mahakapuge TA, Jayawardana NU, Rajapakse J, Gamage CU, Seneviratne B, Perera U, Kanmodi KK, Jayasinghe RD. Diagnostic potential of salivary IL-1β, IL-8, SAT, S100P, and OAZ1 in oral squamous cell carcinoma, oral submucous fibrosis, and oral lichen planus based on findings from a Sri Lankan cohort. Scientific Reports. 2024 Nov 8;14(1):27226.
